Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
OverweightObesity
Interventions
DRUG

pramlintide acetate

Clear, colorless, sterile solution for SC administration

Trial Locations (10)

Unknown

Research Site, Chula Vista

Research Site, Long Beach

Research Site, San Diego

Research Site, DeLand

Research Site, Fort Lauderdale

Research Site, Lexington

Research Site, Baton Rouge

Research Site, New Orleans

Research Site, Butte

Research Site, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY